Diagnostics & prognostics

As molecular diagnostic methods evolve, so does our approach to microbial testing…

Clinical use of GC-ion mobility spectrometry has great potential, but major hurdles lie ahead

It’s time to accept that ovarian cancer doesn’t exist – and to address the knowledge gap in pelvic cancers

Could macular degeneration be diagnosed through blood plasma analysis?

Diagnosis of familial amyloid polyneuropathy can be both tricky and slow – but a different approach could hold the answer

We talk to Maria Montes-Bayón about mentors and the role of mass spectrometry in the field of human health.

An inexpensive, smartphone-based device could offer a wide range of point-of-care tests.

New tests can speed up the diagnosis of severe sepsis, ensuring patients get the right treatment.

Gut mucus microbiota could lead to earlier diagnosis, or even prediction, of inflammatory bowel disease.

As we develop new POCTs for resource-limited settings, the humble sheet of paper has a lot to offer.